John A. Orwin

Director, NeurogesX Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Travere Therapeutics, Inc. TVTX39,375 shares⁷$2.0M at $50.55May 19, 2026
ANAPTYSBIO, INC ANAB17,995 shares⁸$853.3K at $47.42Sep 15, 2026
First Tracks Biotherapeutics, Inc. TRAX17,995 shares⁹$651.2K at $36.19Sep 15, 2026
Seagen SGEN0 shares¹⁰Dec 14, 2023
Atreca, Inc.77,541 shares¹¹Apr 17, 2024

As of each latest filing. The line shows shares held over time.

Sep 15, 2026Exercised options 1,300 shares of ANAPTYSBIO, INC⁸
Sep 15, 2026Exercised options 1,300 shares of First Tracks Biotherapeutics, Inc.⁹
Jun 15, 2026Exercised options 6,030 shares of ANAPTYSBIO, INC¹²
Jun 15, 2026Exercised options 6,030 shares of First Tracks Biotherapeutics, Inc.¹³
May 19, 2026Granted 4,000 shares of Travere Therapeutics, Inc.⁷
Sep 15, 2025Exercised options 1,300 shares of ANAPTYSBIO, INC¹⁴
Jun 15, 2025Exercised options 6,030 shares of ANAPTYSBIO, INC¹⁵
May 15, 2025Granted 6,500 shares of Travere Therapeutics, Inc.¹⁶
Sep 15, 2024Exercised options 1,300 shares of ANAPTYSBIO, INC¹⁷
Jun 15, 2024Exercised options 2,035 shares of ANAPTYSBIO, INC¹⁸
May 8, 2024Granted 6,500 shares of Travere Therapeutics, Inc.¹⁹
Apr 11, 2024Bought 1 shares at $0.01 of Atreca, Inc.¹¹
Dec 14, 2023Returned to company 29,003 shares at $229.00 of Seagen¹⁰
Sep 1, 2023Sold 22,951 shares at $0.37 of Atreca, Inc.²⁰
May 31, 2023Granted 2,044 shares of Seagen²¹
May 17, 2023Granted 4,500 shares of Travere Therapeutics, Inc.²²
Sep 2, 2022Sold 20,908 shares at $1.78 of Atreca, Inc.²³
May 13, 2022Granted 1,503 shares of Seagen²⁴
May 11, 2022Granted 3,000 shares of Travere Therapeutics, Inc.²⁵

The numbers on this page point here. Each one links to the record it came from.